Dexamethasone Tablet Franchise in Ahmedabad

Anti-Inflammatory Tablet Supplier in Mumbai

Immunosuppressant Medicine Distributor in Delhi

Corticosteroid Pharma Franchise in Bangalore

Dexamethasone Tablet Stockist in Hyderabad
Anti-Inflammatory & Allergy Tablet Manufacturer & Exporter in Chandigarh

Home/Products /dexamethasone-4mg-tablet

Dexaflip 4 Tablet

Composition : Dexamethasone (4mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹0/-

Dexaflip 4 Tablet contains Dexamethasone 4mg, a potent corticosteroid for managing inflammation, autoimmune disorders, and allergic reactions. It helps reduce swelling, suppress excessive immune response, and alleviate pain, making it a valuable therapy in multiple clinical conditions.

This tablet is widely prescribed for arthritis, asthma, skin disorders, and various autoimmune diseases, providing patients with effective symptom control and improved quality of life.

For franchise partners, Dexaflip 4 Tablet represents a high-demand product in the anti-inflammatory and immunosuppressant segment, offering strong repeat prescriptions and consistent market acceptance. Its clinical relevance ensures profitable business opportunities and portfolio growth.

With the rising need for effective anti-inflammatory and immune-modulating therapies, Dexaflip 4 Tablet offers sustainable sales potential, helping partners strengthen their presence in the corticosteroid care segment.

Read More

About the Product

Dexaflip 4 Tablet contains Dexamethasone 4mg, a potent corticosteroid for managing inflammation, autoimmune disorders, and allergic reactions. It helps reduce swelling, suppress excessive immune response, and alleviate pain, making it a valuable therapy in multiple clinical conditions.

This tablet is widely prescribed for arthritis, asthma, skin disorders, and various autoimmune diseases, providing patients with effective symptom control and improved quality of life.

For franchise partners, Dexaflip 4 Tablet represents a high-demand product in the anti-inflammatory and immunosuppressant segment, offering strong repeat prescriptions and consistent market acceptance. Its clinical relevance ensures profitable business opportunities and portfolio growth.

With the rising need for effective anti-inflammatory and immune-modulating therapies, Dexaflip 4 Tablet offers sustainable sales potential, helping partners strengthen their presence in the corticosteroid care segment.

Common side effects may include increased appetite, weight gain, mood changes, insomnia, and gastrointestinal discomfort. Long-term use may lead to elevated blood sugar, osteoporosis, or increased susceptibility to infections. Any severe or persistent side effects should be reported to a healthcare professional immediately.

Dexaflip 4 Tablet is indicated for the treatment of inflammatory and allergic conditions such as arthritis, asthma, severe allergic reactions, skin disorders, and certain autoimmune diseases. It may also be used as part of therapy for certain endocrine disorders and in the management of specific types of cancers, as prescribed by a physician.

Common side effects may include increased appetite, weight gain, mood changes, insomnia, and gastrointestinal discomfort. Long-term use may lead to elevated blood sugar, osteoporosis, or increased susceptibility to infections. Any severe or persistent side effects should be reported to a healthcare professional immediately.

Store Dexaflip 4 Tablet in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children and do not use after the expiry date mentioned on the pack.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation